New drug combo targets deadly brain tumors in early trial
Disease control
Terminated
This early-phase study tests whether adding the experimental drug S-Gboxin to standard radiation and chemotherapy can help people with glioblastoma or diffuse midline glioma, two aggressive brain cancers. About 10 participants whose tumors have returned or worsened will receive t…
Phase: PHASE1 • Sponsor: Petrov, Andrey • Aim: Disease control
Last updated May 17, 2026 10:43 UTC